ACE and lipoprotein glomerulopathy: Additionally, given that ACEi are sometimes used in SCD with a view to preventing the progression of glomerulopathy [22], we investigated the effects of an inhibitor of ACE, enalapril, on the BP and RAS components of mice with SCD, to observe the potential hypotensive effects of such drugs and further understand the mechanism of action of these approaches.